Putting Patients First Blog

JULY 2, 2024

General Comments The NHC appreciates CMS’ commitment to actively engaging with stakeholders, including patients, consumer advocates, and health experts, in implementing the Medicare Drug Price Negotiation Program (DPNP). The NHC provides the following comments to CMS to improve on the steps it has already taken to date.

Drug Pricing 52

Drug Pricing Insurance Coverage and Processing HIPAA Labelling 52

Big Molecule Watch

AUGUST 25, 2023

The Inflation Reduction Act’s Medicare Drug Price Negotiation Program will kick off next week. In anticipation of this announcement, below is a recap of the IRA’s Drug Price Negotiation Program and pending legal challenges to various aspects of the program.

Drug Pricing 40

Drug Pricing Biosimilars Insurance Coverage and Processing Labelling 40

Putting Patients First Blog

DECEMBER 13, 2023

The NHC also held multiple webinars/briefings on the Drug Price Negotiation Program (DPNP), informing patient organizations of the law’s parameters and how to best inform their patients on new developments; NHC staff also listened to all ten DPNP Patient-Focused Listening Sessions and was able to provide valuable insight on the process to its membership. (..)

Insurance Coverage and Processing 52

Insurance Coverage and Processing Drug Pricing Packaging 52